ArticleCell reports2022

A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer.

Stephen Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.